StockNews.AI
MSPR
StockNews.AI
11 hrs

MSP Recovery Announces Reverse Stock Split to Maintain Compliance with Nasdaq's Minimum Bid Price Requirement

1. MSP Recovery announced a 1-for-7 reverse stock split effective September 1, 2025. 2. The split aims to ensure compliance with Nasdaq's $1.00 bid price requirement. 3. Stockholders approved the split; 1.02 million shares will be outstanding post-split. 4. Post-split trading begins on September 2, 2025, under the same MSPR symbol. 5. MSP Recovery leads in healthcare reimbursement solutions, emphasizing data-driven innovations.

Stock Split
+11.53%Current Return
VS
+0.3%S&P 500
$0.421408/28 11:55 AM EDTEvent Start
$0.4708/28 10:47 PM EDTLatest Updated
6m saved
Insight
Article

FAQ

Why Bullish?

The reverse stock split is a strategic move indicating financial discipline. Historically, stocks often rebound post-split due to improved perception among investors.

How important is it?

The need to maintain Nasdaq compliance indicates ongoing operational viability, influencing investor confidence. However, success will depend on future performance metrics following the split.

Why Short Term?

Immediate focus on compliance with Nasdaq could provoke trading interest, influencing price shortly after the split. Past examples show quick stock movements after such events.

Related Companies

MSPRHealthcare-related stocksNASDAQ Composite
MIAMI, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ: MSPR) (the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that it will affect a reverse stock split of its Class A common stock at a reverse stock split ratio of 1-for-7, effective at 11:59 P.M. on September 1, 2025, in order to maintain compliance with the minimum $1.00 bid price per share requirement of Nasdaq’s Marketplace Rule 5450(a)(1). The Company’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “MSPR” and will begin trading on a split-adjusted basis when the Nasdaq opens on September 2, 2025 (“Effective Time”). The new CUSIP number for the Company’s Class A common stock following the reverse split will be 553745-40-7. The Company’s stockholders previously approved the reverse stock split and granted the Company’s board of directors the authority to determine the final reverse stock split ratio and when to proceed with the reverse stock split. The Company has filed an amendment to its Second Amended and Restated Certificate of Incorporation to affect the reverse stock split at the ratio of 1-for-7, as of the Effective Time. As a result of the reverse split, every seven (7) shares of the Company’s issued and outstanding Common Stock will automatically be converted into one share of issued and outstanding Common Stock. The Company’s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market open on September 2, 2025. Immediately after the reverse split becomes effective, there will be approximately 1.02 million shares of Class A common stock issued and outstanding. About MSP Recovery Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. MSP Recovery innovates technologies and provides comprehensive solutions for multiple industries including healthcare and legal. For more information, visit: msprecovery.com. Forward Looking Statements This release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSP Recovery herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for the Company to predict or identify all such events or how they may affect it. MSP Recovery has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, the Company’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; the inability of MSP Recovery to obtain financing and generate revenues sufficient to cover the cost of operations; the inherent uncertainty surrounding settlement negotiations and/or litigation, including with respect to both the amount and timing of any such results; the validity of the assignments of claims to MSP Recovery; the ability to successfully expand the scope of the Company’s claims or obtain new data and claims from the Company’s existing assignor base or otherwise; the Company’s ability to innovate and develop new solutions, and whether those solutions will be adopted by the Company’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those additional factors included in MSP Recovery’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the Securities and Exchange Commission. These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995. For Media Inquiries: media@msprecovery.com For Investor Inquiries: investors@msprecovery.com

Related News